CAD 0.03
(20.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -606.96 Thousand CAD | 61.35% |
2022 | -1.57 Million CAD | 33.4% |
2021 | -2.35 Million CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -381.84 Thousand CAD | 17.9% |
2024 Q3 | -172.5 Thousand CAD | 54.82% |
2024 Q1 | -465.12 Thousand CAD | 23.37% |
2023 Q3 | -823.14 Thousand CAD | 13.61% |
2023 FY | -606.96 Thousand CAD | 61.35% |
2023 Q1 | -1.14 Million CAD | 27.06% |
2023 Q2 | -952.78 Thousand CAD | 16.82% |
2023 Q4 | -606.96 Thousand CAD | 26.26% |
2022 Q3 | -1.84 Million CAD | 5.32% |
2022 FY | -1.57 Million CAD | 33.4% |
2022 Q4 | -1.57 Million CAD | 14.74% |
2022 Q1 | 2.35 Million CAD | 200.0% |
2022 Q2 | -1.94 Million CAD | -182.5% |
2021 Q4 | -2.35 Million CAD | 0.0% |
2021 FY | -2.35 Million CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
AI/ML Innovations Inc. | -3732.00 CAD | -16163.746% |
Pangenomic Health Inc. | 952.18 Thousand CAD | 163.744% |
nDatalyze Corp. | -794.1 Thousand CAD | 23.566% |
Treatment.Com International Inc. | -273.39 Thousand CAD | -122.01% |
Unidoc Health Corp. | -324.03 Thousand CAD | -87.317% |